Service Hotline:
互联网药品信息服务资格证书：（陕）-非经营性-2023-0143
About Us
About us
—— ABOUT US
Good Doctor • Hot perfusion
Xi’an Good Doctor Medical Science and Technology Co., Ltd.
Xi’an Good Doctor Medical Science and Technology Co., Ltd. is a specialized medical technology company that is one of the first in China and abroad to adopt continuous circulating hot perfusion treatment technology.
Our company focuses on the field of constant temperature continuous circulating hot perfusion treatment technology, incorporating new clinical technologies that have emerged in recent years, such as intrathoracic and intra-abdominal chemotherapy and postoperative abdominal thermal lavage. This technology can effectively prevent and treat postoperative cancer implantation and metastasis, while also effectively controlling the cancerous effusion generated after metastasis; it fundamentally curbs the recurring "rebound" problem of tumor postoperative metastasis and cancerous effusion, successfully addressing a series of challenges recognized by the medical community, such as unstable temperature, uneven heat distribution, and high incidence of adhesions during traditional intraluminal hot perfusion. It has undeniable scientific, innovative, and clinical practicality.
The company's technical team has a strong medical background, with team members engaged in controlling postoperative metastasis and addressing malignant effusion for over ten years, possessing rich clinical treatment experience; our products have more than 20 independent intellectual property rights, including 4 invention patents; at the same time, patents have also been obtained in regions such as Australia, Germany, Russia, the United States, the European Union, South Korea, Canada, and Africa.
The company's strategy is to provide specialized clinical solutions before, during, and after surgery for the population of "preventing and treating tumor implantation metastasis, and curbing cancerous effusion in body cavities." The company has a 2000 square meter clean room, has passed ISO13485 quality management system certification, and has completed 140 clinical trials in 8 centers in Xi'an, Nanjing, Sichuan, Jilin, Anhui, and Shanxi regions within China, having obtained EU CE certification and domestic NMPA registration.
Our company focuses on the field of constant temperature continuous circulating hot perfusion treatment technology, incorporating new clinical technologies that have emerged in recent years, such as intrathoracic and intra-abdominal chemotherapy and postoperative abdominal thermal lavage. This technology can effectively prevent and treat postoperative cancer implantation and metastasis, while also effectively controlling the cancerous effusion generated after metastasis; it fundamentally curbs the recurring "rebound" problem of tumor postoperative metastasis and cancerous effusion, successfully addressing a series of challenges recognized by the medical community, such as unstable temperature, uneven heat distribution, and high incidence of adhesions during traditional intraluminal hot perfusion. It has undeniable scientific, innovative, and clinical practicality.
The company's technical team has a strong medical background, with team members engaged in controlling postoperative metastasis and addressing malignant effusion for over ten years, possessing rich clinical treatment experience; our products have more than 20 independent intellectual property rights, including 4 invention patents; at the same time, patents have also been obtained in regions such as Australia, Germany, Russia, the United States, the European Union, South Korea, Canada, and Africa.
The company's strategy is to provide specialized clinical solutions before, during, and after surgery for the population of "preventing and treating tumor implantation metastasis, and curbing cancerous effusion in body cavities." The company has a 2000 square meter clean room, has passed ISO13485 quality management system certification, and has completed 140 clinical trials in 8 centers in Xi'an, Nanjing, Sichuan, Jilin, Anhui, and Shanxi regions within China, having obtained EU CE certification and domestic NMPA registration.
Mobile
-
TEL： +86 29 82681864
Fax：+86 29 82681864 E-mail：gd029@126.comAdd: Building 1, Huoju Road, East zone of Xi’an High-tech Development District, Xi'an, China
互联网药品信息服务资格证书（陕）-非经营性-2023-0143